<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM NUTRACEUTICAL INTERNATIONAL CORPORATION'S FINANCIAL POSITION AS OF JUNE 30, 2000 AND THE RESULTS OF ITS OPERATIONS FOR THE NINE MONTHS ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> SEP-30-2000 <PERIOD-START> OCT-01-1999 <PERIOD-END> JUN-30-2000 <CASH> 977 <SECURITIES> 0 <RECEIVABLES> 10,949 <ALLOWANCES> 1,232 <INVENTORY> 26,840 <CURRENT-ASSETS> 40,095 <PP&E> 31,842 <DEPRECIATION> 15,356 <TOTAL-ASSETS> 110,231 <CURRENT-LIABILITIES> 9,940 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 118 <OTHER-SE> 58,488 <TOTAL-LIABILITY-AND-EQUITY> 110,231 <SALES> 81,876 <TOTAL-REVENUES> 81,876 <CGS> 42,711 <TOTAL-COSTS> 42,711 <OTHER-EXPENSES> 29,545 <LOSS-PROVISION> 99 <INTEREST-EXPENSE> 2,153 <INCOME-PRETAX> 7,467 <INCOME-TAX> 2,912 <INCOME-CONTINUING> 4,555 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 4,555 <EPS-BASIC> 0.39 <EPS-DILUTED> 0.37